Hazards associated with the microbiological contamination of cosmetics, toiletries and non-sterile pharmaceuticals

Microbial Quality Assurance in Pharmaceuticals, Cosmetics, and Toiletries

Volumn , Issue , 2017, Pages 9-27

  Spooner, D F ^a  

^a The Boots Company PLC   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 8444250564     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (103)

1. Ahearn, D. G., Wilson, L. A., Reinhardt, D. J., and Julian, A. J. (1974) Microbial contamination in eye cosmetics. Contamination during use. Dev. Ind. Microbiol. 15 211-214.
2. Anderson, R. L., Berkelman, R. L., and Holland, B. W. (1983) Microbiologic investigations with iodophor solutions. Proc. Int. Symp. Povidone, University of Kentucky Press, Lexington, KY, pp. 146-157.
3. Anon. (1958a) Failures of disinfectants to disinfect. Lancet ii 306.
4. Anon. (1958b) Bacteria in antiseptic solutions. Br. Med. J. 2 436.
5. Anon. (1968) Medicines Act. HMSO, London.
6. Anon. (1971a) Microbial contamination in pharmaceuticals for oral and topical use: Society's working party report. Pharm. J. 207 400-402.
7. Anon. (1971b) Microbial contamination of medicines administered to hospital patients: report by Public Health Laboratory Service Working Party. Pharm. J. 207 96-99.
8. Anon. (1976) Benzalkonium chloride: failures as an antiseptic. J. Am. Med. Assoc. 236 2433.
9. Ayliffe, G. A. J., Lowbury, E. J. L., Hamilton, J. G., Small, J. M., Asheshov, E. A., and parker, μ. T. (1965) Hospital infections with Pseudomonas aeruginosa in neurosurgery. Lancet ii 365-368.
10. Ayliffe, G. A. J., Barry, D. R., Lowbury, E. J. L., Roper-Hall, M. J., and Walker, W. M. (1966) Postoperative infection with Pseudomonas aeruginosa in an eye hospital. Lancet i 1113-1117.
11. Ayliffe, G. A. J., Barrowcliff, D. F., and Lowbury, E. J. L. (1969) Contamination of disinfectants. Br. Med. J. 1 505-511.
12. Baird, R. M. (1977) Microbial contamination of cosmetic products. J. Soc. Cosmet. Chem. 28 17-20.
13. Baird, R. M. (1981) Drugs and cosmetics. In: Rose, A. H. (ed.), Microbial biodeterioration. Academic Press, London, pp. 387-426.
14. Baird, R. M. (1985) Microbial contamination of pharmaceutical products made in a hospital pharmacy: a nine year survey. Pharm. J. 231 54-56.
15. Baird, R. M., and shooter, R. A. (1976). Pseudomonas aeruginosa infections associated with use of contaminated medicaments. Br. Med. J. 2 349-350.
16. Baird, R. M., Farwell, J. A., Sturgiss, M., Awad, ζ. A., and Shooter, R. A. (1979) Microbial contamination of topical medicaments used in the treatment and prevention of pressure sores. J. Hyg. 83 445-450.
17. Baird, R. M., Awad, Z. A., Shooter, R. A., and Noble, W. C. (1980) Contaminated medicaments in use in a hospital for diseases of the skin. J. Hyg. 84 103-107.
18. Bassett, D. C. J. (1971) Causes and prevention of sepsis due to Gram-negative bacteria: common sources of outbreaks. Proc. R. Soc. Med. 64 980-986.
19. Bassett, D. C. J., Stokes, K. J., and Thomas, W. R. G. (1970) Wound infection due to Pseudomonas multivorans. A water-borne contaminant of disinfectant solutions. Lancet i 1188-1191.
20. Berkelman, R. L. Anderson, R. L., Davis, B. J., Highsmith, A. K., Petersen, N. J., Bono, W. W., Cook, E. H. Mackel, M. S., Favero, M. W., and Martone, W. J. (1984) Intrinsic bacterial contamination of a commercial iodophor solution. App. Environ. Microbiol. 47 752-756.
21. Beveridge, E. G. (1975) The microbial spoilage of pharmaceutical products. In: Lovelock, D. W., and Gilbert, R. J. (eds), Microbial aspects of the deterioration of materials. Academic Press, London, pp. 213-235.
22. Beveridge, E. G. (1983) Microbial spoilage and preservation of pharmaceutical products. In: Hugo, W. B., and Russell, A. D. (eds), Pharmaceutical microbiology, Blackwell Scientific, Oxford, pp. 334-353.
23. Bloomfield, S. F. (1988) Biodeterioration and disinfectants. In: Houghton, P. R., Smith, R. N., and Egins, H. O. W. (eds), Biodeterioration Vol. 7. Elsevier Applied Science, Barking, pp. 135-145.
24. Bloomfield, S. F. (1990) Microbial contamination: spoilage and hazard. In: Denyer, S. P., and Baird, R. M. (eds), Guide to microbiological control in pharmaceuticals. Ellis Horwood, Chichester, pp. 29-52.
25. Bond, W. W., Favero, M. S., Peterson, ν. J., and Cook, E. J. (1983) Observations on the intrinsic bacterial contamination of iodophor germicides. Proc. Ann. Met. Amer. Soc. Microbiol. 0 Q-133.
26. Bruch, C W. (1972) Possible modification of LISP microbial limits and test. Drug Cosmet. Ind. 110 32-37, 116-121.
27. Burdon, D. W., and Whitby, J. l. (1967) Contamination of hospital disinfectants with Pseudomonas species. Br. Med. J. 2 153-155.
28. Butler, N. j. (1968) The microbiological deterioration of cosmetics and pharmaceutical products. In: Biodeterioration of materials. Elsevier, Amsterdam, pp. 269-280.
29. Cooke, E. M., Shooter, R. A., O'Farrell, S. M., and Martin, D. R. (1970) Faecal carriage of Pseudomonas aeruginosa by newborn babies. Lancet ii 1045-1046.
30. Cox, P. H., and Sewell, B. A. (1968) The metabolism of steroids by Cladosporium herbarum. J. Soc. Cosmet. Chem. 19 461-467.
31. ElKHOFF, T. C. (1967) Nosocomial salmonellosis due to carmine. Ann. Intern. Med. 66 813-814.
32. Fernandez, G. S., and Genis, M. y. (1979) The formation of aflatoxins in different types of starches for pharmaceutical use. Pharm. Acta Helv. 54 78-81.
33. Gerber, N. N., and Lechevalier, H. A. (1965) Geosmin, an earth-smelling substance isolated from actinomycetes. Appl. Microbiol. 13 935-939.
34. Gilbert, j. (1938) Transmission of incidence of enteric disease by unsterile equipment used for administration of fluid by rectum. J. Am. Med. Assoc. 110 1664-1666.
35. Glencross, E. j. G. (1972) Pancreatin as a source of hospital-acquired Salmonellosis. Br. Med. J. 2 376-378.
36. Greenwood, M. H., and Hooper, W. L. (1982) Personal communication.
37. Greenwood, M. H., and Hooper, W. L. (1983) Chocolate bars contaminated with Salmonella napoli: an infectivity study. Br. Med. J. 286 1394.
38. Groves, M. j. (1973) In: Parenteral products. William Heinemann Medical Books, London, pp. 7-10, 293-296.
39. Guyne, C. j., and Bennet, ε. O. (1959) Bacterial deterioration of emulsion oils. Appl. Microbiol. 7 117.
40. Hardy, P. c, Ederek, G. M., and Matsen, j. M. (1970) Contamination of commercially packaged urinary catheter kits with the pseudomonad EO-1. New Engl. J. Med. 282 33-35.
41. Harris, A. A., Levin, S., and Trenholme, G. M. (1984) Selected aspects of nosocomial infections in the 1980s. Am. J. Med. 77 3-10.
42. Hervey, C. R. (1929) Series of typhoid fever cases infected by rectum. Am. J. Pubi. Health 19 166-171.
43. Hills, S. (1946) The isolation of CI. tetani from infected talc. New Zealand Med. J. 45 419-423.
44. Hitokoto, H., Morozumi, S., Wauke, T., Sakai, S., and Kurata, H. (1978) Fungal contamination and mycotoxin detection of powdered herbal drugs. Appl. Environ. Microbiol. 36 252-256.
45. Holmes, C. j., and Allwood, M. C. (1979) The microbial contamination of intravenous infusions during clinical use. J. Appl. Bacteriol. 46 247-267.
46. Jarvis, B. (1976) Mycotoxins in foods. In: Skinner, S. A., and Carr, j. G. (eds) Microbiology in agriculture, fisheries and food. Academic Press, London, pp. 251-267.
47. Jarvis, J. D., Wynne, C. D., Enwright, l., and Williams, J. D. (1979) Handwashing and antiseptic-containing soaps in hospital. J. Clin. Pathol. 32 732-737.
48. Kallings, L. O. (1973) Contamination of therapeutic agents. In: Contamination in the manufacture of pharmaceutical products. Secretariat of the European Free Trade Association, pp. 17-23.
49. Kallings. O., Ringertz, O., Silverstolpe, L., and Ernerfeldt, F. (1966) Microbiological contamination of medical preparations. Acta Pharm. Suec. 3 219-228.
50. Kedzia, W., Lewon, j., and Wismienski, T. (1961) The breakdown of atropine by bacteria. J. Pharm. Pharmacol. 13 614-619.
51. Komarmy, L. E., Oxley, M., and Brecher, G. (1967) Acquired salmonellosis traced to carmine dye capsules. New Engl. J. Med. 276 850-852.
52. Lang, D. j., Kunz, L. j., Martin, A. R., Schroeder, S. A., and Thomson, l. a. (1967) Carmine as a source of nosocomial salmonellosis. New Engl. J. Med. 276 829-832.
53. McCULLOUGH, N. B., and EISELE, C. W. (1951) Experimental human salmonellosis. J. Infect. Dis. 88 278-289.
54. Madden, j. M., and jackson, G. j. (1981) Cosmetic preservations and microbes: viewpoint of the Food and Drug Administration. Cosmet. Toilet. 96 75-77.
55. Malcolm, S. A. (1976) The survival of bacteria in toiletries. In: Skinner, F. A., and Hugo, W. B. (eds), Inhibition and inactivation of vegetative microbes. Academic Press, London, pp. 305-315.
56. Margalith, P., and Schwartz, y. (1970) Flavour and micro-organisms. Adv. Appl. Microbiol. 12 35-12.
57. Marples, R. R. (1976) Local infections - experimental aspects. J. Soc. Cosmet. Chem. 27 449-457.
58. Matthews, H. W., and Wade, B. W. (1977) Pharmacologically active compounds from microbial origins. Adv. Appl. Microbiol. 21 269-288.
59. Mertz, J. j., Scharer, L., and McClement, j. H. (1967) A hospital outbreak of Klebsiella pneumoniae from inhalation therapy with contaminated aerosol solutions. Am. Rev. Respir. Dis. 95 454-460.
60. Meyers, P. H. (1960) Contamination of barium enema apparatus during use. J. Am. Med. Assoc. 174 129-130.
61. Millership, S. E., Patel, N., and Chattopadhyay, B. (1986) The colonization of patients in an intensive treatment unit with Gram-negative flora: the significance of the oral route. J. Hosp. Infect. 7 226-235.
62. Morse, L. j. Williams, H. I., Grenn, F. P., Eldridge, E. F., and Rotta, j. R. (1967) Septicaemia due to Klebsiella pneumoniae originating from a handcream dispenser. New Engl. J. Med. 277 472-473.
63. Neu, H. C. (1978) Clinical role of Pseudomonas aeruginosa. In: Gilardi, G. L. (ed.), Glucose nonfermenting Gram-negative bacteria in clinical microbiology. CRC Press, West Palm Beach, FL, pp. 83-104.
64. Noble, W. C, and savin, j. A. (1966) Steroid cream contaminated with Pseudomonas aeruginosa. Lancet i 347-349.
65. Noble, W. C, and Somerville, D. A. (1974) In: Microbiology of human skin. W. B. Saunders, London.
66. Noble, W. C, and White, P. M. (1969) Pseudomonads and man. Trans. St John's Hosp. Dermatol. Soc. 55 202-208.
67. Norton, D. A., Davies, j. G., Richardson, N. ε., Mεακiν, B. j., and Keall, A. (1974) The antimicrobial efficiencies of contact lens solutions. J. Pharm. Pharmacol. 26 841-846.
68. Omelianski, V. C. (1923) Aroma-producing micro-organisms. J. Bacteriol. 8 393-415.
69. Parker, M. T. (1972) The clinical significance of the presence of micro-organisms in pharmaceutical and cosmetic preparations. J. Soc. Cosmet. Chem. 23 415-426.
70. Parker, M. T. (1984) Hospital acquired infections. In: Wilson, G., Miles, A., and Parker, M. T. (eds), Topley and Wilson's Principles of bacteriology, virology and immunity, Vol. 3. Edward Arnold, London, pp. 280-310.
71. Parrot, P. L., Terry, P. M., Whitworth, ε. ν., Frawley, L. W., Coble, R. S., Wachsmith, I. K., and McGowan, j. E. (1982) Pseudomonas aeruginosa associated with contaminated polaxamer-iodine solutions. Lancet ii 683-684.
72. Pœrce, A. K. and sanford, j. P. (1973) Bacterial contaminations of aerosols. Arch. Intern. Med. 131 156-159.
73. Phillips, I. (1966) Postoperative respiratory tract infection with Pseudomonas aeruginosa due to contaminated lignocaine jelly. Lancet i 903-906.
74. Reid, F. R., and Wood, T. O. (1979) Pseudomonas corneal ulcer. The causative role of contaminated eye cosmetics. Arch. Ophthalmol. 97 1640-1641.
75. Richardson, N. E., Mf.akin, B. j., and Norton, D. A. (1979) Containers, preservatives and contact lens solutions. Pharm. J. 223 462-164.
76. Rmgertz, O., and Ringertz, S. H. (1982) The clinical significance of microbial contamination in pharmaceutical products. Adv. Pharm. Sci. 5 201-225.
77. Rosenheim (1973) In: Report on the prevention of microbial contamination of medicinal products. HMSO, London.
78. Rowe, B., and Hall, M. L. (1975) Salmonella contamination of therapeutic panel preparations. Br. Med. J. 2 51.
79. Sanders, C. V., Luby, j. B., Johanson, W. G., Barnett, J. A., and Sanford, J. P. (1970) Serratia marcescens infections from inhalation therapy medications: nosocomial outbreak. Ann. Intern. Med. 73 15-21.
80. Sautter, R. L., Mattman, L. H., and legaspi, R. C. (1984) Serratia marcescens meningitis associated with a contaminated benzalkonium chloride solution. Infect. Control 5 223-225.
81. Savin, J. A. (1967) The microbiology of topical preparations in pharmaceutical practice. 1. Clinical aspects. Pharm. J. 199 285-288.
82. Schaffner, W., Reisig, G., and Verrall, R. A. (1973) Outbreak of Ps. cepacia infections due to contaminated anaesthetics. Lancet i 1050-1051.
83. Shooter, R. A., Cooke, E. M. Gaya, H., Kumar, P. Patel. N., Parker, M. T., Thom, B. T., and France, D. r. (1969) Food and medicaments as possible sources of hospital strains of Pseudomonas aeruginosa. Lancet i 1227-1231.
84. Somerville, P. C, and summers, r. S. (1979) The clinical implications of contaminated pharmaceutical products. Cent. Afr. J. Med. 25 195-198.
85. Smart, R., and Spooner, D. F. (1972) Microbiological spoilage in pharmaceuticals and cosmetics. J. Soc. Cosmet. Chem. 23 721-737.
86. Spooner, D. F. (1977) Microbiological aspects of the EEC Cosmetics Directive. Cosmet. Toilet. 92 42-51.
87. Spooner, D. F. (1985) Microbiological criteria for non-sterile pharmaceuticals. Manuf. Chem. 56 No. 4, 41-45, No. 5, 71-75.
88. Spooner, D. F., and Corbett, r. J. (1985) The rational use of preservatives in cosmetics and toiletries. Proceedings of Symposium on Formulating Better Cosmetics 25-27 March 1985. Society of Cosmetic Chemists, London, pp. 1-13.
89. Spooner, D. F., and Croshaw, B. (1981) Challenge testing - the laboratory evaluation of the preservation of pharmaceutical preparations. Pharm. Weekbl. 116 245-251.
90. Steinbach, H. L., Rousseau, R., McCormack, K. R., and Jawetz, E. (1960) Transmission of enteric pathogens by barium enema. J. Am. Med. Assoc. 174 1207.
91. Stephenson, J. r., Head, S. R., Richards, M. A., and Tabaqchali, S. (1984) Outbreak of septicaemia due to contaminated mouthwash. Br. Med. J. 289 1584.
92. Sussman, M., and Stevens, J. (1960). Pseudomonas pyocyanea wound infection: an outbreak in an orthopaedic unit. Lancet ii 734-736.
93. Sykes, G. (1971) The control of microbial contamination in pharmaceutical products for oral and topical use - raw materials. J. Mond. Pharm. 14 8-20.
94. Templeton, W. C, Eiferman, r. A., Snyder, J. W., Melo, j. C, and Raff, M. J. (1982) Serratia keratitis transmitted by contaminated eyedroppers. Am. J. Ophthalmol. 93 723-726.
95. Tremewan, H. C (1946) Tetanus neonatorum in New Zealand. New Zealand Med. J. 45 312-313.
96. Victorin. L. (1967) An epidemic of otitis in newborns due to infection with Pseudomonas aeruginosa. Acta Paediatr. Scand. 56 344-348.
97. Von Graevenltz, A. (1977) The role of opportunistic bacteria in human disease. Annu. Rev. Microbiol. 31447-471.
98. Williams, R. E. O. (1967) Spread of airborne bacteria pathogenic for man. In: Gregory, P. H., and Monteith, J. L. (eds), Airborne microbes. Society of General Microbiology, Cambridge, pp. 268-285.
99. Wills, B. A. (1958) Fungal growth in syrup of tolu. J. Pharm. Pharmacol. 120 302-305.
100. Wilson, L. A., and Ahearn, D. G. (1977) Pseudomonas-mâuctá corneal ulcers associated with contaminated eye mascaras. Am. J. Ophthalmol. 84 112-119.
101. Wilson, L. A., Kuehne, J. W., Hall, S. W., and Ahearn, D. G. (1971) Microbial contamination in ocular cosmetics. Am. J. Ophthalmol. 71 1298-1302.
102. Wilson, L. A., Julian, A. J., and Ahearn, D. G. (1975) The survival and growth of microorganisms in mascara during use. Am. J. Ophthalmol. 79 596-601.
103. Wogan, G. N. (1975). Mycotoxins. Annu. Rev. Pharmacol. 15 437-451.